Short answer: No. As of November 13, 2026, Novo Nordisk and Eli Lilly have not announced any settlement of the GLP-1 injury lawsuits, no jury has returned a verdict, and no bellwether trial is scheduled. Any “average Ozempic settlement” figure online is a forecast, not money that has been paid.
Settlement talks in mass torts usually follow key court rulings. Here, the next one is the decision on the expert-evidence (Rule 702) issues heard in September 2026. Until then, nobody can tell you what a case is worth.
- What would drive value if a deal comes: the injury (for example surgery for a blockage versus a shorter illness), objective test results, hospital time, lost income and age.
- What does not exist yet: a fund, a payout matrix or a claims deadline.
- Beware: anyone promising a specific dollar amount for a GLP-1 claim today.
We track the docket and update this page when anything changes. Start with a free, confidential case review.


